MyFinsight
Home
About
Contact
rprx: the income statement
Download
Download image
Royalty Income Other
$30,479K
(-3.31%↓ Y/Y)
Financial Royalty Assets
$578,812K
(8.56%↑ Y/Y)
Interest income
$6,903K
(-60.57%↓ Y/Y)
Gains on available for
sale debt securities
$52,480K
(-9.02%↓ Y/Y)
Total income and other
revenues
$609,291K
(7.90%↑ Y/Y)
(gains)/losses on equity
securities
$18,863K
(-62.90%↓ Y/Y)
Gains on derivative
financial instruments
$4,000K
(33.33%↑ Y/Y)
Equity in
(earnings)/losses of equity method...
$15,948K
(53.24%↑ Y/Y)
Total other
(income)/expense, net
$17,055K
(-76.07%↓ Y/Y)
Operating income
$427,156K
(-41.89%↓ Y/Y)
Other non-operating
expenses/(income), net
-$1,575K
(4.78%↑ Y/Y)
Interest expense
$79,564K
(19.63%↑ Y/Y)
Total operating
expense/(income), net
$182,135K
(206.90%↑ Y/Y)
Consolidated net income
before tax
$444,211K
(-44.91%↓ Y/Y)
General and
administrative expenses
$118,734K
(109.33%↑ Y/Y)
Research and development
funding expense
$50,500K
(10000.00%↑ Y/Y)
Provision for credit
losses on unfunded...
$766K
Provision for changes in
expected cash flows from...
$12,135K
(105.33%↑ Y/Y)
Consolidated net income
$444,211K
(-44.91%↓ Y/Y)
Net income
attributable to royalty...
$288,217K
(-47.02%↓ Y/Y)
Net income
attributable to...
$155,994K
(-40.54%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
1-svg
Royalty Pharma plc (RPRX)
1-svg
Royalty Pharma plc (RPRX)